00:24:38 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Scott+Scott, Attorneys at Law, LLP Announces Investigation into NantHealth, Inc. (NASDAQ: NH)

2017-05-18 13:31 ET - News Release


Company Website: http://www.scott-scott.com
NEW YORK -- (Business Wire)

Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, announces the commencement of an investigation into NantHealth, Inc. (NASDAQ: NH) (“NantHealth” or the “Company”) to determine whether NantHealth’s officers and directors breached their fiduciary duties owed to the Company and its shareholders. If you are a current NantHealth shareholder, you are encouraged to contact Scott+Scott for additional information.

NantHealth, Inc. operates as a healthcare cloud-based information technology company. The Company offers a clinical platform that provides actionable health information at the point of care.

On March 6, 2017, STAT, a news organization focused on medical industry reporting, published an article stating that the Company’s founder, Patrick Soon-Shiong, had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth.

What You Can Do

If you are a NantHealth shareholder, you may have legal claims against NantHealth’s officers and directors. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew at (844) 818-6982, or at jpettigrew@scott-scott.com.

About Scott+Scott, Attorneys at Law, LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Contacts:

Scott+Scott, Attorneys at Law, LLP
Joe Pettigrew, 844-818-6982
jpettigrew@scott-scott.com

Source: Scott+Scott, Attorneys at Law, LLP

© 2024 Canjex Publishing Ltd. All rights reserved.